Aster Capital Management’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
Aster Capital Management's NVCT Position: Q3 2026 in Review
Aster Capital Management opened a new position in Nuvectis Pharma (NVCT) in Q3 2026: 558 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #754 among its holdings.
95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- Aster Capital Management held 558 shares of Nuvectis Pharma worth $11.8K as of Q3 2026.
- Nuvectis Pharma was a new Aster Capital Management position in Q3 2026.
- Nuvectis Pharma made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #754 holding.
- 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.